Singapore markets close in 4 hours 14 minutes

ASLAN Pharmaceuticals Limited (ASLN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5400+0.0490 (+9.98%)
At close: 04:00PM EDT
0.5200 -0.02 (-3.70%)
After hours: 07:43PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
12,000
12,000
0
0
0
Cost of revenue
0
0
0
0
0
Gross profit
12,000
12,000
0
0
0
Operating expenses
Research development
42,495
42,495
38,000
22,021
9,314
Selling general and administrative
13,240
13,240
9,882
11,825
7,169
Total operating expenses
55,662
55,662
47,605
33,815
16,183
Operating income or loss
-43,662
-43,662
-47,605
-33,815
-16,183
Interest expense
4,327
4,327
3,668
1,861
1,247
Total other income/expenses net
3,502
3,502
-451.485
4,085
458.437
Income before tax
-44,087
-44,087
-51,283
-31,591
-16,971
Income tax expense
132.667
132.667
99.221
0
0
Income from continuing operations
-44,220
-44,220
-51,382
-31,591
-16,971
Net income
-44,220
-44,220
-51,382
-31,322
-16,198
Net income available to common shareholders
-44,220
-44,220
-51,382
-31,322
-16,198
Basic EPS
-3.00
-2.75
-3.75
-2.50
-2.00
Diluted EPS
-3.00
-2.75
-3.75
-2.50
-2.00
Basic average shares
15,614
16,450
13,949
13,027
7,689
Diluted average shares
15,614
16,450
13,949
13,027
7,689